Bladder Cancer,Genitourinary Cancer CheckMate 274 Trial: Adjuvant Nivolumab vs Placebo in MIUC Analysis Mar 14, 2023
Bladder Cancer,Genitourinary Cancer JAVELIN Bladder 100: Avelumab for Advanced UC in Subgroups Mar 14, 2023
Genitourinary Cancer Phase 3 Trial on Lenvatinib Plus Pembrolizumab vs. Sunitinib in Advanced RCC Mar 13, 2023
Genitourinary Cancer Comparing Adjuvant Nivolumab and Ipilimumab for Localised RCC: CheckMate 914 Mar 13, 2023
Genitourinary Cancer TRITON3 Trial: Rucaparib vs. Physician’s Choice for Metastatic Prostate Cancer Mar 13, 2023
Genitourinary Cancer,Popular,RCC (Renal Cell Carcinoma) CheckMate 214 Study: Clinical Efficacy of NIVO+IPI in sRCC Patients Feb 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CheckMate 9ER Trial: Cabozantinib and Nivolumab Combination Therapy for Advanced RCC Feb 27, 2023
